Related Experiment Video
Updated: Dec 20, 2025
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Clinical outcomes for congenital heart disease patients presenting with infective endocarditis
1Department of Pediatric Cardiology and Congenital Heart Disease, Claude Bernard Lyon 1 Medical University, Cardiovascular Hospital Louis Pradel , Lyon, France.
Insights
Infective endocarditis (IE) is increasingly affecting adults with congenital heart disease (CHD). Advances in diagnosis and treatment are needed to improve outcomes for this growing patient population.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Diagnostics
Background:
- Infective endocarditis (IE) poses a significant threat to patients with congenital heart disease (CHD).
- Despite diagnostic and therapeutic advancements, IE incidence remains a concern.
- The growing adult CHD population presents unique challenges for IE management.
Purpose of the Study:
- To review the epidemiology of IE in congenital heart disease (CHD) patients.
- To explore novel diagnostic techniques, including imaging and microbial identification.
- To assess current therapeutic strategies, surgical interventions, and prophylaxis guidelines.
Main Methods:
- Literature review focusing on keywords: congenital heart disease, infective endocarditis, diagnosis, treatment, and prophylaxis.
- Analysis of epidemiological trends, diagnostic modalities, and treatment outcomes.
- Evaluation of current clinical guidelines and emerging technologies.
Main Results:
- IE incidence is rising in the adult CHD population, particularly those with residual lesions or prosthetic materials.
- Diagnosis can be challenging, but advanced imaging like PET-scan aids in identifying intracardiac lesions and embolic foci.
- Mortality rates for IE remain significant (10-20%) despite improved diagnostics and therapies.
Conclusions:
- IE management in adults with CHD requires tailored approaches due to complex cardiac conditions.
- Innovations in surgical techniques aim to minimize prosthetic material use.
- Prophylaxis strategies now emphasize daily oral and skin hygiene.
Introduction:
Infective endocarditis (IE) is a life-threatening adverse event for patients with congenital heart disease (CHD). Its incidence has changed little over time despite progress in techniques for diagnosis and treatment, and guidelines for prophylaxis.
Areas Covered:
The review sought for key-words: 'congenital heart disease,' 'infective endocarditis,' 'microbial diagnosis,' 'imaging diagnosis,' 'surgical techniques,' 'prognosis,' 'prophylaxis.' Objectives were to investigate epidemiology, novel techniques for imaging and microbial diagnosis, therapeutic management and prognosis, and guidelines for prophylaxis in patients with CHD. The incidence of IE is increasing in adults with CHD. Morbidity caused by a broad clinical spectrum of cardiac and extracardiac episode-related complications is high. Surgical management is increasingly required in the early phase of the disease. Despite new techniques for diagnosis and microbiological therapy, mortality rate is still up to 10-20%.
Expert Opinion:
IE has increased in the growing cohort of adults with complex heart disease, living with residual cardiac lesions and prosthetic materials. Diagnosis is challenging for complex heart defects. Pet-scan technique can provide beneficial information to locate intracardiac lesions and embolic foci. Identification of the microbiological agents is improving. Innovative surgical techniques aim to avoid prosthetic material. Guidelines for prophylaxis currently emphasize oral and skin daily hygiene.
Related Concept Videos
01:25Endocarditis I: Introduction
01:29Endocarditis IV: Nursing Management
01:25Endocarditis II: Clinical Features of Infective Endocarditis
01:18Endocarditis III: Medical Management
01:23Rheumatic Heart Disease I: Introduction
01:27Myocarditis II: Clinical Features and Diagnostic Tests